To evaluate the effectiveness of risk-weighted apoB in predicting coronary heart disease compared to traditional lipid biomarkers.
Analysis of risk-weighted apoB considering particle number and atherogenicity
Comparison with conventional lipid biomarkers
Evaluation of clinical risk stratification effectiveness
Risk-weighted apoB demonstrated superior predictive ability for coronary heart disease
Clinically meaningful improvements in identifying high-risk individuals
Abstract
RW-apoB represents not only particle number but also accounts for the higher atherogenicity of TRL and Lp(a). It offers clinically meaningful improvements in CHD risk stratification.